CMPX

Compass Therapeutics (CMPX)

About Compass Therapeutics (CMPX)

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Details

Daily high

$1.93

Daily low

$1.80

Price at open

$1.88

52 Week High

$2.34

52 Week Low

$0.76

Market cap

261.4M

Dividend yield

0.00%

Volume

271,821

Avg. volume

431,041

P/E ratio

-5.32

Compass Therapeutics News